NCT02413541已完成不适用
The Pilot Study of the Efficacy of Polymyxin-B Hemoperfusion in Critically Ill Patients With Severe Sepsis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 90
- 试验地点
- 2
- 主要终点
- Functions of cell surface markers
研究概览
简要总结
This research project is a study to immunology changes in critically ill patients with severe sepsis by using Endotoxin Activity Assay (EAA) combined with Polymyxin-B Hemoperfusion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Care Provider)
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •SIRS Criteria > or = 2 meets definition
- •Source of infection > or = 1 meet definition
- •Evidence of organ dysfunction > or = 1 meet definition
排除标准
- •WBC < 5,000 /ul
- •Platelet < 30,000 / ul
- •Pregnancy woman
- •Advance stage cancer patients (terminally ill) who is refuse to be resuscitated
- •Received blood transfusion > 5 units in 24 hrs
- •Allergy to Polymyxin-B
- •High risk and uncontrolled bleeding
- •Organ transplant patients
- •On immunosuppressive agents within 2 weeks before study
- •HIV infection
结局指标
主要结局
Functions of cell surface markers
时间窗: 3 days
CD11b expression on PMN and HLA-DR expression on monocyte
EAA level
时间窗: 3 days
Endotoxin level
Chemotaxis
时间窗: 3 days
Neutrophil function
次要结局
- Sequential Organ Failure Assessment (SOFA Score)(28 days)
- Survival rate(28 days)
- Acute Kidney Injury and Renal Replacement Therapy incidences(28 days)
- ICU length of stay(28 days)
- Mechanical ventilation free day(28 days)
研究者
Nattachai Srisawat ,M.D.
Division of Nephrology, Department of Medicine, Faculty of Medicine
Chulalongkorn University
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis PatientsSepsisNCT05911711Kangdong Sacred Heart Hospital120
已完成
不适用
Mechanistic Inflammatory Sub-study Embedded Within the Albumin vs Balanced Crystalloid TrialSepsisNCT04963569University of Edinburgh26
尚未招募
1 期
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of SepsisFluid OverloadEndothelial DysfunctionMicrocirculationSepsisNCT06626984Belfast Health and Social Care Trust65
Unknown
不适用
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With SepsisSepsisNCT01535534Universitätsmedizin Mannheim250
终止
不适用
Efficacy of Polymyxin B Hemoperfusion on Severe Sepsis Secondary to Pneumonia or Urinary Tract InfectionSepsisNCT02871024National Taiwan University Hospital1